The prevention of potentially fatal food-induced anaphylaxis in the growing number of people with food intolerance currently requires strict avoidance of the allergen. However, a recent study by Zhou et al. provides hope of an alternative. In a mouse model of food allergy, exposure to the allergen normally leads to severe, if not fatal, hypersensitivity, but the authors were able to confer tolerance in these mice by orally sensitising them with a sugar-modified form of the allergen before feeding with the unmodified form. It was found that a receptor on lamina propria dendritic cells, SIGNR1, bound the sugar-modified allergen, which led to the production of the immunosuppressive cytokine interleukin-10 and, subsequently, to the generation of CD4+ type 1 regulatory T (Tr1)-like cells; these cells transferred tolerance when injected into naive mice. Future studies will determine whether the immune system’s response to food allergens can also be altered in this way in humans.
Preventing food-induced anaphylaxis
Preventing food-induced anaphylaxis. Dis Model Mech 28 October 2010; 3 (11-12): 664. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists